翡翠临床试验赢得2026年亚太生物药品卓越奖,以表彰患者招聘和参与。 Emerald Clinical Trials wins 2026 Asia Pacific Biopharma Excellence Award for patient recruitment and engagement.

翡翠临床试验获得2026年亚太生物药品卓越奖,表彰其在患者征聘和临床试验参与方面取得的成就。 Emerald Clinical Trials has been awarded the 2026 Asia Pacific Biopharma Excellence Award for its achievements in patient recruitment and engagement within clinical trials. 承认突出了该公司在加强参与和维持病人参与整个亚太地区的研究方面采取的创新办法。 The recognition highlights the company’s innovative approaches to increasing participation and maintaining patient involvement in research across the Asia Pacific region. 该奖项强调日益强调生物制药发展中以患者为中心的做法。 The award underscores growing emphasis on patient-centered practices in biopharmaceutical development.